Open-label Study on Treatment of Primary Aldosteronism With Everolimus
Clinical trial NCT03174171 · COMPLETED
Trial details
- NCT number
- NCT03174171
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-22
- Primary completion
- 2018-06-25
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.